Register for real-time alerts, custom portfolio, and market movers

Get Started

Home
Investing
Stocks
USA
NASDAQ
Marker Therapeutics Inc (MRKR)
Marker Therapeutics Inc (MRKR) News

MRKR

Marker Therapeutics (MRKR)

Marker Therapeutics Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:MRKR

<< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >>

Date	Time	Source	Headline	Symbol	Company
08/09/2019	8:32AM	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:MRKR	Marker Therapeutics Inc
08/09/2019	6:11AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:MRKR	Marker Therapeutics Inc
08/08/2019	5:09PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:MRKR	Marker Therapeutics Inc
08/08/2019	5:08PM	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:MRKR	Marker Therapeutics Inc
08/08/2019	4:01PM	PR Newswire (US)	Marker Therapeutics Reports Second Quarter 2019 Operating and Financial Results	NASDAQ:MRKR	Marker Therapeutics Inc
08/06/2019	4:50PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:MRKR	Marker Therapeutics Inc
08/06/2019	4:05PM	PR Newswire (US)	Marker Therapeutics Appoints Steve Elms to its Board of Directors	NASDAQ:MRKR	Marker Therapeutics Inc
07/22/2019	8:36AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:MRKR	Marker Therapeutics Inc
07/20/2019	11:00AM	PR Newswire (US)	Marker Therapeutics Reports Interim Results of its MultiTAA T Cell Therapy in Patients with Pancreatic Adenocarcinoma at AACR	NASDAQ:MRKR	Marker Therapeutics Inc
07/19/2019	9:14AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:MRKR	Marker Therapeutics Inc
07/17/2019	7:00AM	PR Newswire (US)	Marker Therapeutics to Host Conference Call and Webcast to Review Interim Results from Phase 1/2 Clinical Trial with its Mult...	NASDAQ:MRKR	Marker Therapeutics Inc
06/26/2019	6:02AM	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:MRKR	Marker Therapeutics Inc
06/20/2019	7:06AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:MRKR	Marker Therapeutics Inc
06/20/2019	7:00AM	PR Newswire (US)	Marker Therapeutics to Report Updated Results from Phase 1/2 Trial with MultiTAA Therapy in Patients with Pancreatic Adenocar...	NASDAQ:MRKR	Marker Therapeutics Inc
06/14/2019	4:07PM	Edgar (US Regulatory)	Securities Registration Statement (simplified Form) (s-3)	NASDAQ:MRKR	Marker Therapeutics Inc
05/21/2019	7:00AM	PR Newswire (US)	Marker Therapeutics to Present at Two Upcoming Investor Conferences	NASDAQ:MRKR	Marker Therapeutics Inc
05/15/2019	4:12PM	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:MRKR	Marker Therapeutics Inc
05/13/2019	4:03PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:MRKR	Marker Therapeutics Inc
05/13/2019	4:03PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:MRKR	Marker Therapeutics Inc
05/13/2019	4:03PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:MRKR	Marker Therapeutics Inc
05/13/2019	4:02PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:MRKR	Marker Therapeutics Inc
05/10/2019	5:07PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:MRKR	Marker Therapeutics Inc
05/10/2019	5:05PM	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:MRKR	Marker Therapeutics Inc
05/09/2019	5:11PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:MRKR	Marker Therapeutics Inc
05/09/2019	4:01PM	PR Newswire (US)	Marker Therapeutics Reports First Quarter 2019 Operating and Financial Results	NASDAQ:MRKR	Marker Therapeutics Inc
05/07/2019	4:10PM	PR Newswire (US)	Marker Therapeutics to Present at the Bank of America Merrill Lynch Health Care Conference	NASDAQ:MRKR	Marker Therapeutics Inc
04/17/2019	7:01AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:MRKR	Marker Therapeutics Inc
04/01/2019	1:58PM	Edgar (US Regulatory)	Confidential Treatment Order (ct Order)	NASDAQ:MRKR	Marker Therapeutics Inc
03/28/2019	5:20PM	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:MRKR	Marker Therapeutics Inc
03/28/2019	5:16PM	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:MRKR	Marker Therapeutics Inc

Showing the most relevant articles for your search:NASDAQ:MRKR

<< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >>

Canopus Biopharma (PK)

Gold and GemStone Mining (PK)

Marketing Worldwide (PK)

Virexit Technologies (PK)

Bell Buckle (PK)

Ubiquitech Software (PK)

Brookmount Explorations (PK)

NioCorp Developments

Anavex Life Sciences

Fannie Mae (QB)

Decentral Life (PK)

Seven Arts Entertainment (PK)

Delayed Upgrade Clock